Global Magnetoencephalography Market Outlook
Revenue, 2024
Forecast, 2034
CAGR, 2024 - 2034
Magnetoencephalography is becoming increasingly popular in fields like neuromarketing and neuroscience research due to its non invasive nature and its ability to offer detailed insights, into brain functionality.
Market Key Insights
- The Magnetoencephalography market is projected to grow from $376.2 million in 2024 to $768 million in 2034. This represents a CAGR of 7.4%, reflecting rising demand across Functional Brain Mapping, Assisting in the Diagnosis and Research of Neurological Disorders and Pre-surgical Planning.
The market exhibits an oligopolistic structure with only 6 prominent players, with Compumedics Limited and MEGIN commanding the largest shares.
- U.S. and Japan are the top markets within the Magnetoencephalography market and are expected to observe the growth CAGR of 4.8% to 7.1% between 2024 and 2030.
- Emerging markets including India, South Korea and Brazil are expected to observe highest growth with CAGR ranging between 8.5% to 10.2%.
Transition like Advancements in Software Algorithms is expected to add $54.4 million to the Meg Magnetoencephalography market growth by 2030
- The Magnetoencephalography market is set to add $392 million between 2024 and 2034, with manufacturer targeting Epilepsy & Stroke Application Scope projected to gain a larger market share.
- With Advanced medical imaging capabilities, and Rising prevalence of neurological disorders, Magnetoencephalography market to expand 104% between 2024 and 2034.
Opportunities in the Magnetoencephalography
With the rise in ML and AI technologies, the magnetoencephalography field has the potential to exponentially grow. ML algorithms can enhance the interpretation of MEG data, making diagnosis faster and more efficient, impacting the market positively
Growth Opportunities in North America and Europe
North America Outlook
In North America the Magnetoencephalography market is led by factors such as an incidence of neurological disorders and access to advanced healthcare services making it a hub, for medical research investment. The regions notable MEG equipment manufacturers further fuel market expansion. However intense competition prompts these manufacturers to constantly innovate to uphold their market share. Potential lies in enhancing the precision and effectiveness of devices.
Europe Outlook
Europe represents the largest market for Magnetoencephalography due to factors such as a growing elderly population facing neurodegenerative conditions and robust governmental backing for healthcare studies is fuel this markets growth trajectory significantly The competition in this sector is intense with industry players prioritizing innovations in MEG technology The potential, for progression can be found in integrating AI and ML tools into MEG systems to elevate their diagnostic functionalities.
Market Dynamics and Supply Chain
Driver: Advanced Medical Imaging Capabilities, and Technological Innovations in MEG Systems
The increasing prevalence of conditions on a global scale like Alzheimers disease and Parkinsons disease has also led to a rise in the need for MEG systems in clinical settings, for diagnosing these illnesses effectively and thereby boosting its market expansion.
Restraint: High Cost of MEG Devices
Opportunity: Expanding Clinical Applications and Increasing Demand in Developing Regions
In emerging areas there is a growing need for diagnostic equipment such as MEG due to the uptick in neurological conditions observed in these regions there has been an increased focus towards improving healthcare standards and enhancing neuro diagnostic capabilities creating significant market potential, in these regions.
Challenge: Limited Specialists and Technicians
Supply Chain Landscape
ArcelorMittal
BHP Group
Rio Tinto Group
Siemens Healthineers
Hitachi High-Technologies Corporation
Elekta
York Instruments
MEGIN
Elekta
Medical and Healthcare Industry
Research Institutes
Hospitals
ArcelorMittal
BHP Group
Rio Tinto Group
Siemens Healthineers
Hitachi High-Technologies Corporation
Elekta
York Instruments
MEGIN
Elekta
Medical and Healthcare Industry
Research Institutes
Hospitals
Applications of Magnetoencephalography in Functional Brain Mapping, Assisting in the Diagnosis & Research of Neurological Disorders & Pre-surgical Planning
MEG is widely employed for mapping brain functions by pinpoint brain region's linked to various functions due to its non invasive nature and real time brain activity capture capabilities which distinguish it as a valuable tool in understanding brain functionality effectively. Key players in the market such, as Elekta and MEGIN have crafted MEG systems with exceptional temporal resolution.
MEG is also crucial for surgery assessments as it helps pinpoint the precise site of abnormal brain activity and offers neurosurgeons a clear guide for operations that reduce risks and improve results – especially during epilepsy surgery or when removing tumors close, to vital brain regions. York Instruments and other companies are working on MEG systems to assist in this important process.
MEG is essential for diagnosing and studying neurological conditions such as epilepsy and autism while also helping with stroke and Alzheimers research by offering detailed insights into the development of these diseases due to its high temporal resolution technology. Companies, like Eleka and MEGIN are well known for offering MEG systems that play a crucial role in this field.
Recent Developments
Eleckta AB has introduced a state of the art MEG system designed for research institutions to enhance neurological clinical decision making.
MEGTECH introduced COHTREY. A cutting edge Magnetoencephalography system tailored to meet the increasing need, for neurological diagnostics.
Medtronic plc acquired York Instruments to broaden their range of Magnetoencephalography devices and strengthen their market reach.